MYNZ (Mainz Biomed NV) Operating Cash Flow per Share : $-26.07 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Operating Cash Flow per Share?

Mainz Biomed NV's operating cash flow per share for the three months ended in Dec. 2024 was $0.00. Mainz Biomed NV's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was $-26.07.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -98.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Mainz Biomed NV's Operating Cash Flow per Share or its related term are showing as below:

MYNZ' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -223.2 Med: -208.6 Max: 0.4
Current: 0.4

During the past 6 years, Mainz Biomed NV's highest 3-Year average Operating Cash Flow per Share Growth Rate was 0.40% per year. The lowest was -223.20% per year. And the median was -208.60% per year.

MYNZ's 3-Year OCF Growth Rate is ranked worse than
54.91% of 173 companies
in the Medical Diagnostics & Research industry
Industry Median: 3 vs MYNZ: 0.40

Mainz Biomed NV Operating Cash Flow per Share Historical Data

The historical data trend for Mainz Biomed NV's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Operating Cash Flow per Share Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.60

-17.89

-41.72

-54.04

-17.66

Mainz Biomed NV Quarterly Data
	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial									-13.72	-16.31	-9.76	-	-

Competitive Comparison of Mainz Biomed NV's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Mainz Biomed NV's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mainz Biomed NV's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mainz Biomed NV's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Mainz Biomed NV's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Mainz Biomed NV Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Mainz Biomed NV's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-17.09	/	0.968
	=	-17.65

Mainz Biomed NV's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	0	/	0.968
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.07

Mainz Biomed NV Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Robert Koch Strasse 50, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.